申请人:Sasahara Takehiko
公开号:US20050009805A1
公开(公告)日:2005-01-13
[Object] To provide a medicine useful for treatment and prevention of hyperlipidemia, further for the treatment and prevention of cholestasis-accompanying hepatopathy, particularly primary biliary cirrhosis and primary sclerosing cholangitis, and for the treatment and prevention of obesity and fatty liver.
[Means] A benzothiazepine compound represented by the following formula (1), having a thioamide bond and a quaternary ammonium substituent.
提供一种用于治疗和预防高脂血症,尤其是原发性胆汁性肝病,特别是原发性胆汁性肝硬化和原发性硬化性胆管炎,以及治疗和预防肥胖和脂肪肝的药物。代表如下式(1)的苯并噻二唑化合物,具有硫酰胺键和季铵基取代基。